Infiltrative Type I Collagen in the Treatment of Morton's Neuroma: A Mini-Series.
Morton’s neuroma
US-guided injection
case mini-series
clinical treatment
type I porcine collagen
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
12 Jul 2023
12 Jul 2023
Historique:
received:
09
06
2023
revised:
09
07
2023
accepted:
11
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Morton's neuroma (MN) is a compressive neuropathy of the common plantar digital nerve, most commonly affecting the third inter-digital space. The conservative approach is the first recommended treatment option. However, other different approaches have been proposed, offering several options of treatments, where, several degrees of efficacy and safety have been reported. We treated five consecutive patients affected by MN through three indirect ultrasound-guided injections of type I porcine collagen at weekly intervals. All patients were assessed before the treatment, after the treatment and up to 6 months after the last injection via AOFAS and VNS scores for pain, in which the function and pain were evaluated, respectively. In all patients, both analyzed variables progressively ameliorated, with benefits lasting until the last follow-up. The trend of the scores during the follow-up showed significant statistical differences. No side effects occurred. To our knowledge, this is the first study on injections of type I porcine collagen for the treatment of Morton's neuroma. Future research is needed to confirm the positive trend achieved in this MN mini-series.
Identifiants
pubmed: 37510755
pii: jcm12144640
doi: 10.3390/jcm12144640
pmc: PMC10380245
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
Foot Ankle Spec. 2022 Dec;15(6):579-585
pubmed: 35778874
Foot Ankle Surg. 2018 Aug;24(4):271-281
pubmed: 29409240
Int J Environ Res Public Health. 2021 Jul 27;18(15):
pubmed: 34360245
J Ultrason. 2021 Jun 7;21(85):e134-e138
pubmed: 34258038
Eur Radiol. 2022 Dec;32(12):8414-8422
pubmed: 35726101
J Biol Regul Homeost Agents. 2020 May-Jun;34(3 Suppl. 2):33-39. ADVANCES IN MUSCULOSKELETAL DISEASES AND INFECTIONS - SOT
pubmed: 32856437
Foot Ankle Surg. 2020 Apr;26(3):314-319
pubmed: 31064701
Ortop Traumatol Rehabil. 2019 Dec 31;21(6):427-436
pubmed: 32100719
Foot Ankle Surg. 2020 Oct;26(7):736-743
pubmed: 31718949
Acta Biomed. 2022 Mar 10;92(S3):e2021556
pubmed: 35604266
J Foot Ankle Res. 2019 Feb 13;12:12
pubmed: 30809275
Reumatismo. 2006 Oct-Dec;58(4):319-22
pubmed: 17216022
J Anat. 2015 Nov;227(5):654-64
pubmed: 26467241
BMC Musculoskelet Disord. 2022 Oct 6;23(1):898
pubmed: 36203146
J Foot Ankle Surg. 1996 Mar-Apr;35(2):112-9; discussion 187-8
pubmed: 8722878
Foot Ankle Spec. 2022 Aug 5;:19386400221116466
pubmed: 35932109
Ann Rehabil Med. 2013 Apr;37(2):202-7
pubmed: 23705114
Eur Radiol. 2015 Aug;25(8):2254-62
pubmed: 25809742
Eur J Phys Rehabil Med. 2021 Jun;57(3):366-375
pubmed: 32667151
Physiol Res. 2019 Nov 22;68(Suppl 1):S65-S74
pubmed: 31755292
Clin Orthop Surg. 2021 Jun;13(2):266-277
pubmed: 34094019
Tissue Eng Part A. 2020 May;26(9-10):503-511
pubmed: 31884890
EFORT Open Rev. 2019 Jan 23;4(1):14-24
pubmed: 30800476
Cells. 2018 Dec 06;7(12):
pubmed: 30563214
BMC Musculoskelet Disord. 2022 Dec 20;23(1):1109
pubmed: 36536333
Foot Ankle Surg. 2021 Jun;27(4):357-365
pubmed: 32600970
Cells. 2020 Dec 08;9(12):
pubmed: 33302563
J Clin Med. 2022 Oct 24;11(21):
pubmed: 36362491
Br J Pain. 2021 Nov;15(4):460-473
pubmed: 34840794
Foot Ankle Int. 2017 Sep;38(9):944-951
pubmed: 28617064
Int Orthop. 2010 Apr;34(4):511-5
pubmed: 19484237
J Clin Med. 2022 May 02;11(9):
pubmed: 35566678
J Hand Surg Glob Online. 2022 Apr 28;5(1):97-101
pubmed: 36704377